Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAH, Gralnick HR, Sultan C.
Proposals for the classification of the myelodysplastic syndromes.
Br J Haematol 1982;51:189-199. PM:6952920
[Medline]
Kerkhofs H, Hermans J, Haak HL, Leeksma CHW.
Utility of the FAB classification for myelodysplastic syndromes. Investigation of prognostic factors in 237 cases.
Br J Haematol 1987;65:73-81. PM:3814528
[Medline]
Gattermann N, Aul C, Schneider W.
Two types of acquired idiopathic sideroblastic anaemia (AISA).
Br J Haematol 1990;74:45-52. PM:2310696
[Medline]
Germing U, Gattermann N, Aivado M, Hildebrandt B, Aul C.
Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinction.
Br J Haematol 2000;108:724-728. PM:10792275
[Medline]
Garand R, Gardais J, Bizet M, Bremond JL, Accard F, Callat MP, Tron de Bouchony E, Goasguen JE.
Heterogeneity of acquired idiopathic sideroblastic anemia (AISA).
Leuk Res 1992;16:463-468. PM:1625471
[Medline]
Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S, Irriguible D, San Miguel JF.
Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients.
Blood 1989;74:395-408. PM:2752119
[Medline]
Michaux JL, Martiat P.
Chronic myelomonocytic leukaemia (CMML) - a myelodysplastic or myeloproliferative syndrome?
Leuk Lymphoma 1993;9:35-41. PM:8477199
[Medline]
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD.
World Health Organization of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997.
J Clin Oncol 1999;17:3835-3849. PM:10577857
[Medline]
Germing U, Gattermann N, Strupp C, Aivado M, Aul C.
Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients.
Leuk Res 2000;243:983-992. PM:11077111
[Medline]